Labor Induction-Module 2: Indications, Contraindications, ARRIVE Trial

Labor Induction-Module 2: Indications, Contraindications, ARRIVE Trial

In the US, Mega (> $10M) and Nuclear (> $100M) closed obstetric claims increased 84% in the last decade, and oxytocin misuse is a significant factor. This is module two of a seven-part series that focuses on labor induction indications and contraindications, and implications of the ARRIVE trial on professional organizational guidelines and clinical practice.

  • Provider:LAMMICO/Medical Interactive
  • Activity Link: https://medicalinteractive.com/courses/51398
  • Start Date: 2023-08-21 05:00:00
  • End Date: 2023-08-21 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
  • Commercial Support: No
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: Yes
  • Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments

Warning: file_put_contents(/nas/content/live/sleepliteracy/wp-content/uploads/wpdiscuz/cache/comments/.htaccess): Failed to open stream: Permission denied in /nas/content/live/sleepliteracy/wp-content/plugins/wpdiscuz/utils/class.WpdiscuzCache.php on line 161
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.